EAU20- Results from the phase III study of nadofaregene
Blog - Latest News
You are here: Home1 / Results from the phase III study of nadofaregene firadenovec: Safety and efficacy in patients with high-grade, BCG-unresponsive Non-Muscle Invasive Bladder Cancer2 / EAU20- Results from the phase III study of nadofaregene
Contact
Carolina Urologic Research Center
823 82nd Parkway, Suite B
Myrtle Beach, SC 29572
Phone: (843) 839-1679
Fax: (843) 286-0119
Email:
info@curcmb.com
Recent Happenings
Our Affiliates
Leave a Reply
Want to join the discussion?Feel free to contribute!